Companies

Open Orphan swings to profit for the first time after ‘milestone year’ for the firm

Revenue at the pharmaceutical services company increased almost 80 per cent last year after it secured a number of large contracts

Cathal Friel, executive chairman of Open Orphan, said the company had established itself as the world-leading provider of human challenge trials